CXCL13 and immunodeficiency disease: By the time the study was performed, there was not enough evidence to recommend CXCL13 test as a routine diagnostic tool, and PCR in CSF was recommended in very early LNB with negative IAI, or in patients with immunodeficiency, on the basis of good practice points [3].